## ACMR: ACM Research, Inc. - XLK: Technology

### Executive Summary

PARABOLIC warning: MRS_10 at 9.7% exceeds exhaustion threshold (8.0%). Extreme momentum typically precedes mean reversion. Consider profit-taking or tight stops.

- **Horizon:** 1-5 days (momentum)
- **Risk Profile:** High - extreme momentum reversal risk
- **Stop Type:** Fixed 2xATR ($40.58)
- **If Wrong:** Exit on momentum reversal or stop hit
- **Invalidation:** MRS_10 drops below exhaustion threshold

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 5 ($0.71M) |
| Sells | 5 ($6.09M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Blackrock Inc.: 12.7% (+84.8%)
- Vanguard Group Inc: 8.1% (+12.8%)
- LSV Asset Management: 4.2% (+462.9%)
- Triata Capital Ltd: 3.4% (+26.0%)
- State Street Corpora: 3.3% (+58.6%)

### Key Risks

1. Insider selling cluster: $6.1M in recent transactions.
2. Elevated short interest (8.1%): bears positioning against stock.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Momentum building: MRS_10 improving +8.3% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

Balance sheet: strong liquidity (3.5x). Insider selling cluster ($6.1M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $2.9B |
| Beta | 1.45 |
| 52W Range | $14.97 - $46.13 |
| Short Interest | 8.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | N/A |
| Forward P/E | 21.6 |
| Current P/E | 24.6 |
| YoY Growth | 13.5% |
| EPS Direction | FALLING |

### Technicals

MRS_10 strengthening from 1.4% to 9.7% (+8.3% in 5 days), confirming momentum buildup. Extended beyond STRENGTH zone (9.7% > 6.0%), caution on chasing. MRS_5 at 7.2% confirms short-term momentum alignment. Outperforming sector by 10.0pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). RSI overbought at 72, risk of mean reversion. OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 9.71% (CS: 96) | Strong |
| RSI_14 | 72.0 | Overbought |
| MACD Histogram | 0.50 | Bullish |
| vs SMA20 | 1.143x | Above |
| vs SMA50 | 1.227x | Above |
| vs SMA200 | 1.504x | Above |

### Decision

- **Verdict:** SELL
- **Thesis:** PARABOLIC

### Trade Setup

- **Entry:** $45.00
- **Stop Loss:** $40.58 (9.8% risk)
- **Target:** $49.42 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** PARABOLIC thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 260
- **Position Value:** $11,700.00
- **Portfolio %:** 11.70%
- **Risk Dollars:** $1,150.00
- **Risk Per Trade:** 1.15%
- **Modifiers:** L1 115% | L2 100% | Combined 1.15x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-02-25 (Est: $0.47)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.53 | $0.36 | -32.4% |
| 2025Q2 | $0.50 | $0.54 | +7.5% |
| 2025Q1 | $0.35 | $0.46 | +32.4% |
| 2024Q4 | $0.39 | $0.56 | +44.5% |

---
*RULE-based L3 | 2026-01-07 09:35 | MRS_10*